Evonik stock jumps on reports BASF may make new offer; Citi discusses numbers
Evonik Industries' shares rose 2.6% after Reuters reported BASF may submit a new takeover offer. BASF's initial offer of €22.15 per share was rejected in September. Citi analysts estimate a potential €25 per share offer could boost BASF's earnings and cash flow by 20% through 2030, but may reduce return on invested capital to 9%.
How this was made
The 30-second read
Why it matters
The news could trigger short‑term buying in Evonik and cause market participants to reassess BASF's valuation and balance sheet.
Market read
New M&A rumor creates immediate price movement for Evonik and prompts strategic considerations for BASF and the broader chemicals sector.
What to watch
Regulatory approval risk and RAG shareholder opposition could delay or block the transaction.
Background
The article reports a fresh Reuters scoop that BASF may launch a second takeover bid for Evonik after an earlier rejected offer.
Ticker impact
BASF is cited as the possible acquirer in the reported new takeover offer for Evonik.
potential modest downside as investors assess financing and integration risks
The news focuses on Evonik's upside; BASF impact is secondary and uncertain.
Market effects
Signals possible consolidation in the European specialty chemicals sector.
May boost German market sentiment if the deal is viewed positively.
Highlights ongoing M&A activity in the chemicals industry, relevant to global investors.
Counterpoint
Deal could fall apart, leading to a sell‑off in Evonik if expectations are not met.
Key entities
- companyEvonik Industries AG
German specialty chemicals producer, target of the potential BASF bid.
- companyBASF SE
World's largest chemical producer, potential acquirer of Evonik.
